AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2025 Earnings Call Transcript November 7, 2025
Operator: Good afternoon, and welcome to AbCellera’s Third Quarter 2025 Business Update Conference Call. My name is Cameron, and I’ll facilitate the audio portion of today’s interactive broadcast. [Operator Instructions] At this time, I would like to turn the call over to Tryn Stimart, AbCellera’s Chief Legal and Compliance Officer. You may proceed.
Tryn Stimart: Thank you. Hello, everyone. Thank you for...
